Acticor Biotech
Marilyn has over 20 years’ experience in pharmaceutical development and global clinical project management especially in oncology, virology and Intensive care unit.
She previously assumed the functions of International Clinical Project Manager in pharmaceutical companies and CRO (Clinical Research Organization).
Before that, she spent the beginning of her career in marketing and participated in the launching of several innovative products in oncology for Chiron and Aventis.
Acticor Biotech
Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of an innovative therapeutic strategy for safe and effective emergency treatment of ischemic strokes which account for 80% of all strokes.